CAT9 Group Inc. (CATN) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
ROOM 2001, DADING CENTURY SQUARE, NO 387 CHENGDU, 610000 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2021 MRQ | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2015 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 7 | 189 | 120 | 169 | ||||
| Cash and cash equivalent | 7 | 189 | 120 | 169 | ||||
| Receivables | 14 | 429 | 12 | 34 | ||||
| Inventory, net of allowances, customer advances and progress billings | 307 | 235 | 142 | 3 | ||||
| Inventory | 307 | 235 | 142 | 3 | ||||
| Prepaid expense | 2 | 13 | ||||||
| Advances on inventory purchases | 167 | 97 | 78 | 64 | ||||
| Other current assets | 6 | 34 | 46 | 17 | ||||
| Total current assets: | 501 | 986 | 411 | 286 | ||||
| Noncurrent Assets | ||||||||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 12 | 22 | 42 | 52 | ||||
| Other undisclosed noncurrent assets | 4 | 13 | ||||||
| Total noncurrent assets: | 16 | 36 | 42 | 52 | ||||
| TOTAL ASSETS: | 518 | 1,022 | 453 | 338 | ||||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 511 | 811 | 152 | 58 | ||||
| Accrued liabilities | 58 | |||||||
| Other undisclosed accounts payable and accrued liabilities | 511 | 811 | 152 | |||||
| Debt | 114 | 72 | 87 | 77 | ||||
| Other liabilities | 1 | 23 | 16 | |||||
| Due to related parties | 184 | 417 | 466 | 151 | 16 | |||
| Other undisclosed current liabilities | 428 | 29 | 345 | 50 | ||||
| Total current liabilities: | 1,238 | 1,352 | 1,065 | 336 | 16 | |||
| Noncurrent Liabilities | ||||||||
| Total liabilities: | 1,238 | 1,352 | 1,065 | 336 | 16 | |||
| Equity | ||||||||
| Equity, attributable to parent | (720) | (330) | (612) | 2 | (16) | |||
| Common stock | 10 | 10 | 10 | 10 | 1 | |||
| Additional paid in capital | 498 | 498 | 498 | 404 | 4 | |||
| Accumulated other comprehensive loss | (29) | (12) | (2) | (10) | ||||
| Accumulated deficit | (1,199) | (826) | (1,118) | (402) | (20) | |||
| Total equity: | (720) | (330) | (612) | 2 | (16) | |||
| TOTAL LIABILITIES AND EQUITY: | 518 | 1,022 | 453 | 338 | ||||
Income Statement (P&L) ($ in thousands)
| 9/30/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 1,572 | 5,593 | 462 | 333 | |||
| Cost of revenue | (710) | (2,272) | (253) | (146) | |||
| Cost of product and service sold | (22) | (54) | |||||
| Gross profit: | 862 | 3,321 | 209 | 187 | |||
| Operating expenses | (1,513) | (3,054) | (924) | (382) | (20) | ||
| Operating income (loss): | (651) | 267 | (715) | (195) | (20) | ||
| Nonoperating income (expense) | 278 | 25 | (1) | 3 | |||
| Investment income, nonoperating | 1 | ||||||
| Other nonoperating income (expense) | 324 | 39 | (1) | ||||
| Interest and debt expense | (9) | (1) | |||||
| Income (loss) from continuing operations: | (382) | 293 | (717) | (193) | (20) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | (382) | 293 | (717) | (193) | (20) | |
| Other undisclosed net income | 9 | ||||||
| Net income (loss): | (373) | 293 | (717) | (193) | (20) | ||
| Other undisclosed net income attributable to parent | 1 | ||||||
| Net income (loss) available to common stockholders, diluted: | (373) | 293 | (716) | (193) | (20) | ||
Comprehensive Income ($ in thousands)
| 9/30/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | (373) | 293 | (717) | (193) | (20) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (373) | 293 | (717) | (193) | (20) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.